ConductScience.org, home

Paper25547792

Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.

Rondini S and 9 others. Infect Immun, 2015. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium. Papers, record 25547792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25547792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
PubMed
Journal
Infect Immun
PubMed
Year
2015
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
1.96
iCite
Revised in PubMed
2025-05-29
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rondini SS
2Micoli FF
3Lanzilao LL
4Gavini MM
5Alfini RR
6Brandt CC
7Clare SS
8Mastroeni PP
9Saul AA
10MacLennan CAC A

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, BacterialMajor topic
GlycoconjugatesMajor topic
O AntigensMajor topic
Salmonella Infections, AnimalMajor topic
Salmonella VaccinesMajor topic
Salmonella typhimuriumMajor topic
Animals
Bacterial Proteins
Diphtheria Toxin
Drug Design
Female
Glycosylation
Humans
Liver
Mice
Mice, Inbred C57BL
Mutation
Recombinant Proteins
Spleen
Structure-Activity Relationship
Vaccination

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BB/I002189/1Biotechnology and Biological Sciences Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123803904Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States.Clin Vaccine Immunol2013https://conductscience.org/library/papers/23803904PubMed
219477560Quadrivalent meningococcal conjugate vaccines.Vaccine2009https://conductscience.org/library/papers/19477560PubMed
310678970Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.Infect Immun2000https://conductscience.org/library/papers/10678970PubMed
423142430A scalable method for O-antigen purification applied to various Salmonella serovars.Anal Biochem2013https://conductscience.org/library/papers/23142430PubMed
518953717Lipopolysaccharide: a tool and target in enterobacterial vaccine development.Biol Chem2008https://conductscience.org/library/papers/18953717PubMed
621248155Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi.Clin Vaccine Immunol2011https://conductscience.org/library/papers/21248155PubMed
721677750A conditional knockout resource for the genome-wide study of mouse gene function.Nature2011https://conductscience.org/library/papers/21677750PubMed
8387597Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.Infect Immun1979https://conductscience.org/library/papers/387597PubMed
98698499
Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.
Infect Immun1996https://conductscience.org/library/papers/8698499PubMed
107529745Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen.Infect Immun1995https://conductscience.org/library/papers/7529745PubMed
1111422320Lipopolysaccharide O-chain microheterogeneity of Salmonella serotypes Enteritidis and Typhimurium.Environ Microbiol2001https://conductscience.org/library/papers/11422320PubMed
1218628492Growth-phase regulation of lipopolysaccharide O-antigen chain length influences serum resistance in serovars of Salmonella.J Med Microbiol2008https://conductscience.org/library/papers/18628492PubMed
136203984Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.J Immunol1984https://conductscience.org/library/papers/6203984PubMed
1420133627Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20133627PubMed
156166555Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice.Infect Immun1981https://conductscience.org/library/papers/6166555PubMed
163546260Lysogenic conversion of Salmonella typhimurium bacteriophages A3 and A4 consists of O-acetylation of rhamnose of the repeating unit of the O-antigenic polysaccharide chain.J Bacteriol1987https://conductscience.org/library/papers/3546260PubMed
1719346477Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19346477PubMed
181639490Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.Infect Immun1992https://conductscience.org/library/papers/1639490PubMed
1919797066Effect of the O-antigen length of lipopolysaccharide on the functions of Type III secretion systems in Salmonella enterica.Infect Immun2009https://conductscience.org/library/papers/19797066PubMed
2010496944Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice.Infect Immun1999https://conductscience.org/library/papers/10496944PubMed

See all 52 referencesDownload CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
42750268Critical Roles of O-Acetylation Revealed by Synthetic Trisaccharide Antigens for a Broad-Spectrum Anti-Salmonella Vaccine.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42750268PubMed
42095411Synthetic O-Polysaccharide Backbone Units for a Single Antigen Vaccine Against Two Major Non-Typhoidal Salmonella Serovars.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/42095411PubMed
41493384Multivalent vaccines for invasive Salmonella disease: need, rationale, and immunological foundations.Infect Immun2026https://conductscience.org/library/papers/41493384PubMed
41471961Characterization of a Luminescence-Based Serum Bactericidal Activity Assay for Human Sera Against a Panel of Salmonella Strains.Microorganisms2025https://conductscience.org/library/papers/41471961PubMed
40684736Non-typhoidal Salmonella combination vaccines: clinical development plan and regulatory considerations.Vaccine2025https://conductscience.org/library/papers/40684736PubMed
40006669The Salmonella Paratyphi A O-Antigen Glycoconjugate Vaccine Is Able to Induce Antibodies with Bactericidal Activity Against a Panel of Clinical Isolates.Vaccines (Basel)2025https://conductscience.org/library/papers/40006669PubMed
39591175Design of a Glycoconjugate Vaccine Against Salmonella Paratyphi A.Vaccines (Basel)2024https://conductscience.org/library/papers/39591175PubMed
38264668
A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal Salmonella serovars.
Front Immunol2023https://conductscience.org/library/papers/38264668PubMed
38006003
Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A.
Vaccines (Basel)2023https://conductscience.org/library/papers/38006003PubMed
36234967Impact and Control of Sugar Size in Glycoconjugate Vaccines.Molecules2022https://conductscience.org/library/papers/36234967PubMed
34893630Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines.NPJ Vaccines2021https://conductscience.org/library/papers/34893630PubMed
34638530Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens.Int J Mol Sci2021https://conductscience.org/library/papers/34638530PubMed
34065899Long-Term Anti-Bacterial Immunity against Systemic Infection by Salmonella enterica Serovar Typhimurium Elicited by a GMMA-Based Vaccine.Vaccines (Basel)2021https://conductscience.org/library/papers/34065899PubMed
33671372A GMMA-CPS-Based Vaccine for Non-Typhoidal Salmonella.Vaccines (Basel)2021https://conductscience.org/library/papers/33671372PubMed
33451348The identification of novel immunogenic antigens as potential Shigella vaccine components.Genome Med2021https://conductscience.org/library/papers/33451348PubMed
32692622Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development.Hum Vaccin Immunother2020https://conductscience.org/library/papers/32692622PubMed
32535667Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM197 as carrier protein.Glycoconj J2020https://conductscience.org/library/papers/32535667PubMed
30262653Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/30262653PubMed
30143807Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines.Adv Biochem Eng Biotechnol2021https://conductscience.org/library/papers/30143807PubMed
29628924Defective Phagocytic Properties of HIV-Infected Macrophages: How Might They Be Implicated in the Development of Invasive Salmonella Typhimurium?Front Immunol2018https://conductscience.org/library/papers/29628924PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25547792

GET https://conductscience.org/api/papers/v1/25547792/references?page=2